Structure of Satraplatin CAS 129580-63-8

Satraplatin CAS 129580-63-8

/in , , /by

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

129580-63-8

Name

Satraplatin

Synonyms

Acetic acid, compd. with cyclohexanamine, platinum(4+) salt, hydrochloride, ammoniate (2:1:1:2:1) [ACD/Index Name]
Chlorure acétate de platine(4+) – cyclohexanamine, ammoniate (2:2:1:1:1) [French] [ACD/IUPAC Name]
Platin(4+)chloridacetat -cyclohexanaminammoniat (1:2:2:1:1) [German] [ACD/IUPAC Name]
Platinum(4+) chloride acetate cyclohexanamine ammoniate (1:2:2:1:1) [ACD/IUPAC Name]
(OC-6-43)-Bis(acetato-0)ammine-dichloro(cyclohexanamine)Platinum (IV)
[129580-63-8]
129580-63-8 [RN]
367265-85-8 [RN]
Bisacetatoammine-dichloro(cyclohexanamine)Platinum (IV)
bis-acetatoamminedichlorocyclohexylamine platinum(IV)
C081294
Cyclohexanamine, platinum complex
JM216
MFCD00871429
platinum(4+) ion cyclohexanamine diacetate amine dichloride
platinum(4+) ion cyclohexylamine diacetate amine dichloride
Platinum, bis(acetato-O)amminedichloro(cyclohexanamine)-, (OC-6-43)-
Platinum, bis(acetato-κO)amminedichloro(cyclohexanamine)-, (OC-6-43)-
Poplat
Satraplatin
UNII:8D7B37T28G
UNII-8D7B37T28G

Molecular Structure

Structure of Satraplatin CAS 129580-63-8

Structure of Satraplatin CAS 129580-63-8

SMILES

CC(=O)[O-].CC(=O)[O-].C1CCC(CC1)N.N.[Cl-].[Cl-].[Pt+4]

StdInChI

InChI=1S/C6H13N.2C2H4O2.2ClH.H3N.Pt/c7-6-4-2-1-3-5-6;2*1-2(3)4;;;;/h6H,1-5,7H2;2*1H3,(H,3,4);2*1H;1H3;/q;;;;;;+4/p-4

StdInChIKey

CKNPWBAXEKSCRG-UHFFFAOYSA-J

Molecular Formula

C10H22Cl2N2O4Pt

Molecular Weight

500.28

Properties

Appearance

Light yellow and odorless crystalline

Specifications and Other Information of Our Satraplatin CAS 129580-63-8

Standard

Enterprise standard

Identification Methods

HPLC,IR

Assay

98.0%~102.0%

Acidity

5.5~6.5

Related substance

If impurity peak appears in HPLC, the sum of impurities peaks should be not more than the area of RS main peak 2.0%

Loss on Drying

≤0.5%

Pt content（Gravimetric method）

38.7%~39.3%

Package

According to customer requirements to packaging

Storage

Under the room temperature and away from light

Application

Used as the API for treatment of lung and ovarian cancers

Links

This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://caming.com/satraplatin-cas-129580-63-8/

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://watson-int.com/satraplatin-cas-129580-63-8/